Login / Signup
Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way.
Gema Ariceta
Published in:
Pediatric nephrology (Berlin, Germany) (2019)
Keyphrases
</>
case report
replacement therapy